Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: A randomized controlled trial

American Journal of Clinical Nutrition

Volumn 102, Issue 5, 2015, Pages 1126-1133

  Burk, Raymond F ^a   Hill, Kristina E ^a   Motley, Amy K ^a   Byrne, Daniel W ^b   Norsworthy, Brooke K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Functional selenium deficiency; Inorganic selenium metabolism; Selenium biomarkers; Selenium metabolism by the liver; Selenium requirement

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; GLUTATHIONE PEROXIDASE 3; METHIONINE; PLACEBO; SELENATE; SELENOMETHIONINE; SELENOPROTEIN; SELENOPROTEIN P; BIOLOGICAL MARKER; GLUTATHIONE PEROXIDASE; GPX3 PROTEIN, HUMAN; SELENIC ACID; SELENIUM;

ABSENCE OF SIDE EFFECTS; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE SEVERITY; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; MALE; MEDICATION COMPLIANCE; MODEL FOR END STAGE LIVER DISEASE SCORE; NUTRITIONAL STATUS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SELENIUM BLOOD LEVEL; SELENIUM DEFICIENCY; TABLET; ADVERSE EFFECTS; BLOOD; COMPARATIVE STUDY; DEFICIENCY; DEFICIENCY DISEASES; DIET THERAPY; DIETARY SUPPLEMENT; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TENNESSEE;

ADULT; BIOMARKERS; DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; METHIONINE; MIDDLE AGED; NUTRITIONAL STATUS; PILOT PROJECTS; SELENIC ACID; SELENIUM; SELENOMETHIONINE; SELENOPROTEIN P; SEVERITY OF ILLNESS INDEX; TENNESSEE;

EID: 84946033049     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.110932     Document Type: Article

References (33)

1. Burk RF, Hill KE, Nakayama A, Mostert V, Levander XA, Motley AK, Johnson DA, Johnson JA, Freeman ML, Austin LM. Selenium deficiency activates mouse liver Nrf2-ARE but Vitamin E deficiency does not. Free Radic Biol Med 2008;44:1617-23.
2. Chen J. An original discovery: selenium deficiency and Keshan disease (an endemic heart disease). Asia Pac J Clin Nutr 2012;21:320-6.
3. Aaseth J, Alexander J, Thomassen Y, Blomhoff JP, Skrede S. Serum selenium levels in liver diseases. Clin Biochem 1982;15:281-3.
4. Bettinger D, Schultheiss M, Hennecke N, Panther E, Knuppel E, Blum HE, Thimme R, Spangenberg HC. Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study. Hepatology 2013;57:2543-4.
5. Burk RF, Early DS, Hill KE, Palmer IS, Boeglin ME. Plasma selenium in patients with cirrhosis. Hepatology 1998;27:794-8.
6. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GH, Patrick MK, Wilcox JA, Ong TH, Lynch SV, Strong R. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56:164-8.
7. Dworkin B, Rosenthal WS, Jankowski RH. Low blood selenium levels in alcoholics with and without advanced liver disease. Dig Dis Sci 1985;30:838-44.
8. Johansson U, Johnsson F, Joelsson B, Berglund M, Akesson B. Selenium status in patients with liver cirrhosis and alcoholism. Br J Nutr 1986;55:227-33.
9. Thuluvath PJ, Triger DR. Selenium in chronic liver disease. J Hepatol 1992;14:176-82.
10. Burk RF, Hill KE, Motley AK. Plasma selenium in specific and nonspecific forms. Biofactors 2001;14:107-14.
11. Food and Nutrition Board, Institute of Medicine. Selenium. In: Dietary reference intakes for Vitamin C, Vitamin E, selenium, and carotenoids. Washington (DC): National Academy Press; 2000. p. 284-324.
12. Burk RF, Hill KE. Regulation of selenium metabolism and transport. Annu Rev Nutr 2015;35:109-34.
13. Esaki N, Nakamura T, Tanaka H, Soda K. Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme. J Biol Chem 1982;257:4386-91.
14. Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, Muller MJ. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr 2003;77:1269-77.
15. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
16. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006;15:804-10.
17. Xia YM, Hill KE, Burk RF. Biochemical studies of a seleniumdeficient population in China: Measurement of selenium, glutathione peroxidase and oxidant defenses in blood. J Nutr 1989;119:1318-26.
18. Koh TS, Benson TH. Critical re-appraisal of fluorometric method for determination of selenium in biological materials. J Assoc Off Anal Chem 1983;66:918-26.
19. Sheehan TMT, Gao M. Simplified fluorometric assay of total selenium in plasma and urine. Clin Chem 1990;36:2124-6.
20. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990;11:116-28.
21. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-70.
22. Méplan C, Crosley LK, Nicol F, Beckett GJ, Howie AF, Hill KE, Horgan G, Mathers JC, Arthur JR, Hesketh JE. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 2007;21:3063-74.
23. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999;70: 896-903.
24. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma is an index of selenium status in seleniumdeficient and selenium-supplemented Chinese subjects. J Nutr 1996; 126:138-45.
25. Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J (Engl) 1979;92:471-6.
26. Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1995;1:433-6.
27. Xia Y, Hill KE, Li P, Xu J, Zhou D, Motley AK, Wang L, Byrne DW, Burk RF. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 2010;92:525-31.
28. Burk RF, Lane JM. Modification of chemical toxicity by selenium deficiency. Fundam Appl Toxicol 1983;3:218-21.
29. Burk RF, Lawrence RA, Lane JM. Liver necrosis and lipid peroxidation in the rat due to paraquat and diquat administration. J Clin Invest 1980;65:1024-31.
30. Schwarz K, Foltz CM. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc 1957;79:3292-3.
31. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, Muti P, Berrino F, Krogh V. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010;10:564.
32. Hill KE, Wu S, Motley AK, Stevenson TD, Winfrey VP, Capecchi MR, Atkins JF, Burk RF. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J Biol Chem 2012;287: 40414-24.
33. Avissar N, Ornt DB, Yagil Y, Horowitz S, Watkins RH, Kerl EA, Takahashi K, Palmer IS, Cohen HJ. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 1994;266:C367-75.